Occurrence, distribution, and risk assessment of selected pharmaceuticals in municipal biosolids from the four wastewater treatment plants in Gauteng Province, South Africa

The presence of pharmaceutical residues in municipal biosolids is an emerging environmental concern due to their potential accumulation in agricultural soils following land application. While parent compounds like sulfamethoxazole and carbamazepine are frequently studied, data on their transformation products in biosolids remain limited. This study assessed the occurrence, distribution, and environmental risks of sulfamethoxazole, carbamazepine, and two of their selected metabolites in biosolids collected from four wastewater treatment plants (WWTPs) in Gauteng Province, South Africa. A single biosolid sampling campaign was conducted across the four WWTPs, each characterized by varying operational parameters. Sulfamethoxazole and its two metabolites were not detected in any of the samples. In contrast, carbamazepine and its metabolites-carbamazepine-10,11-epoxide and carbamazepine diol-were detected, with maximum concentrations of 150.67, 601.95, and 89.18 ng/g dry weight, respectively. Carbamazepine and carbamazepine-10,11-epoxide occurred in all samples, while carbamazepine diol appeared in 50% of the samples. The concentration patterns varied across WWTPs and were significantly correlated with biosolid pH, organic carbon content, and oxidation-reduction potential. Risk quotient analysis indicated that the predicted soil concentrations of carbamazepine (0.50 ng/g dry weight) pose negligible ecological risk (RQ = 0.003). However, due to a lack of ecotoxicological data, environmental risks associated with carbamazepine-10,11-epoxide and carbamazepine diol could not be fully assessed. Overall, the findings highlight the persistence of carbamazepine and its metabolites in biosolids and underscore the importance of optimizing sludge treatment processes and generating toxicity data for pharmaceutical metabolites to support safe land application practices.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-11-24
DOI
https://doi.org/10.1038/s41598-025-29215-8
Citations
1
Primary Topic
Pharmaceutical and Antibiotic Environmental Impacts
Type
article
Field-Weighted Citation Impact
0.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Occurrence, distribution, and risk assessment of selected pharmaceuticals in municipal biosolids from the four wastewater treatment plants in Gauteng Province, South Africa

Eyob Habte Tesfamariam, Madelien Wooding, Sally L. Brown, Matome Peter Ngoetjana
1 citations
Scientific Reports
Pharmaceutical and Antibiotic Environmental Impacts
0.50
article

Occurrence, distribution, and risk assessment of selected pharmaceuticals in municipal biosolids from the four wastewater treatment plants in Gauteng Province, South Africa

Eyob Habte Tesfamariam, Madelien Wooding, Sally L. Brown, Matome Peter Ngoetjana
article en
1 citations

Abstract

The presence of pharmaceutical residues in municipal biosolids is an emerging environmental concern due to their potential accumulation in agricultural soils following land application. While parent compounds like sulfamethoxazole and carbamazepine are frequently studied, data on their transformation products in biosolids remain limited. This study assessed the occurrence, distribution, and environmental risks of sulfamethoxazole, carbamazepine, and two of their selected metabolites in biosolids collected from four wastewater treatment plants (WWTPs) in Gauteng Province, South Africa. A single biosolid sampling campaign was conducted across the four WWTPs, each characterized by varying operational parameters. Sulfamethoxazole and its two metabolites were not detected in any of the samples. In contrast, carbamazepine and its metabolites-carbamazepine-10,11-epoxide and carbamazepine diol-were detected, with maximum concentrations of 150.67, 601.95, and 89.18 ng/g dry weight, respectively. Carbamazepine and carbamazepine-10,11-epoxide occurred in all samples, while carbamazepine diol appeared in 50% of the samples. The concentration patterns varied across WWTPs and were significantly correlated with biosolid pH, organic carbon content, and oxidation-reduction potential. Risk quotient analysis indicated that the predicted soil concentrations of carbamazepine (0.50 ng/g dry weight) pose negligible ecological risk (RQ = 0.003). However, due to a lack of ecotoxicological data, environmental risks associated with carbamazepine-10,11-epoxide and carbamazepine diol could not be fully assessed. Overall, the findings highlight the persistence of carbamazepine and its metabolites in biosolids and underscore the importance of optimizing sludge treatment processes and generating toxicity data for pharmaceutical metabolites to support safe land application practices.

Scientific ReportsVol. 15(1)
University of Washington (US), Seattle University (US), University of Pretoria (ZA)
National Research Foundation, Water Research Commission
Openalex Percentile: Top 32%
Pharmaceutical and Antibiotic Environmental Impacts
0.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.